China Pharma Q3 revenue falls 8.5%
China Pharma’s company’s gross profit increased by 18% to $4.69m as compared to $3.97m for the same quarter in 2009. Operating income decreased by 79% to $689,213 from
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.